- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pharmacy Institutions Failing to Submit Data by Aug 31 to Lose 2025-26 Approval: PCI

New Delhi: The Pharmacy Council of India (PCI) has issued a final reminder to pharmacy institutions seeking approval under Section 12 for the 2025-26 academic session, directing them to submit complete additional information between August 26 and August 31, 2025.
The Council noted that despite repeated opportunities, some institutions have failed to provide the required details. As a result, such institutions were placed in the category of “Not to make admissions in the first year for 2025–26.”
According to the latest circular, several institutions had failed to submit the complete documents within the stipulated time, despite earlier notifications dated 3 July 2025 and 24 July 2025.
In this connection, the Pharmacy Council of India (PCI) informs that—
a) Some institutions have failed to submit the complete additional information regarding u/s 12 approval after repeated opportunities given.
b) Council has conveyed the decision to the institutions to not grant approval u/S 12 for the 2025-2026 academic session and the institutions for said course are placed under the category of "Not to make admission in 1st year" for the 2025-2026 academic session.
However, PCI has now given a last opportunity for compliance. Institutions must ensure that all required tabs on the PCI portal are completely filled within the specified window.
In view of the above, through the recent circular, it is stated,
"The last opportunity to submit the complete additional information and ensure that each and every tab should be filled for considering approval u/s 12 for the 2025-2026 academic session and the portal will be open from 26.8.2025 to 31.8.2025."
The Council has cautioned that failure to meet this deadline will result in applications being summarily rejected and not considered for approval under Section 12 for 2025–26.
To view the official notice, click the link below:
https://medicaldialogues.in/pdf_upload/14-56circular2025-26-299193.pdf
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.